Spojené štáty - angličtina - NLM (National Library of Medicine)

yung shin pharm. ind. co., ltd. - entecavir (unii: 5968y6h45m) (entecavir anhydrous - unii:nnu2o4609d) - entecavir tablets are indicated for the treatment of chronic hepatitis b virus infection in adults and pediatric patients 2 years of age with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (alt or ast) or histologically active disease. none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to entecavir during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary prospective pregnancy data from the apr are not sufficient to adequately assess the risk of birth defects, miscarriage or adverse maternal or fetal outcomes. entecavir use during pregnancy has been evaluated in a limited number of individuals reported to the apr and the number of exposures to entecavir is insufficient to make a risk assessment compared to a reference population. the estimated background rate for major

Kanada - angličtina - Health Canada

pharmascience inc - entecavir - tablet - 0.5mg - entecavir 0.5mg - nucleosides and nucleotides

Kanada - angličtina - Health Canada

pharmascience inc - entecavir - tablet - 1mg - entecavir 1mg - nucleosides and nucleotides

Kanada - angličtina - Health Canada

mint pharmaceuticals inc - entecavir (entecavir monohydrate) - tablet - 0.5mg - entecavir (entecavir monohydrate) 0.5mg - nucleosides and nucleotides

Kanada - angličtina - Health Canada

strides pharma canada inc - entecavir (entecavir monohydrate) - tablet - 0.5mg - entecavir (entecavir monohydrate) 0.5mg - nucleosides and nucleotides

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - entecavir monohydrate 0.532mg equivalent to 0.5 mg entecavir - film coated tablet - 0.5 mg - active: entecavir monohydrate 0.532mg equivalent to 0.5 mg entecavir excipient: magnesium stearate opadry white y-1-7000 silicified microcrystalline cellulose sodium starch glycolate - indicated for the treatment of chronic hepatitis b infection in adults with evidence of active liver inflammation.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - entecavir monohydrate 0.532mg equivalent to 0.5 mg entecavir - film coated tablet - 0.5 mg - active: entecavir monohydrate 0.532mg equivalent to 0.5 mg entecavir excipient: magnesium stearate opadry white y-1-7000 silicified microcrystalline cellulose sodium starch glycolate - indicated for the treatment of chronic hepatitis b infection in adults with evidence of active liver inflammation.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - entecavir monohydrate 1.065mg equivalent to 1.0 mg entecavir - film coated tablet - 1 mg - active: entecavir monohydrate 1.065mg equivalent to 1.0 mg entecavir excipient: magnesium stearate opadry pink 03b240018 silicified microcrystalline cellulose sodium starch glycolate - indicated for the treatment of chronic hepatitis b infection in adults with evidence of active liver inflammation.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - entecavir monohydrate 1.065mg equivalent to 1.0 mg entecavir - film coated tablet - 1 mg - active: entecavir monohydrate 1.065mg equivalent to 1.0 mg entecavir excipient: magnesium stearate opadry pink 03b240018 silicified microcrystalline cellulose sodium starch glycolate - indicated for the treatment of chronic hepatitis b infection in adults with evidence of active liver inflammation.

Kanada - angličtina - Health Canada

sanis health inc - entecavir - tablet - 0.5mg - entecavir 0.5mg